Literature DB >> 4111436

Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane.

J W Heine, P G Spear, B Roizman.   

Abstract

Previous papers in the series have shown that the surface membranes of herpesvirus-infected cells acquire new immunological specificities and that purified infected cell membrane preparations, characterized by their physical properties rather than topology in the cell, contain new glycoproteins genetically determined by the virus. In this study, we prepared purified plasma membrane identified by its 5' nucleotidase, fucose, and reduced nicotinamide adenine dinucleotide-diaphorase content. Analysis of the membrane proteins and glycoproteins by electrophoresis in acrylamide gels indicated the following. (i) Purified plasma membranes from infected cells contained two sets of proteins, i.e., host proteins were present both before and after infection and viral proteins were present only after infection. (ii) After infection, no appreciable selective or nonselective loss of host proteins from membranes was demonstrable. However, no new host proteins were made. (iii) Electropherograms of plasma membrane proteins from infected cells indicated the presence of at least 12 virus-specific proteins ranging in molecular weight from 25 x 10(3) to 126 x 10(3) daltons. Of these, at least nine were glycosylated. Proteins and glycoproteins with similar electrophoretic mobilities but in somewhat different ratios were also present in preparations of highly purified virions.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4111436      PMCID: PMC356316     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Polykaryocytosis.

Authors:  B ROIZMAN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

2.  Entry of vesicular stomatitis virus into L cells.

Authors:  J W Heine; C A Schnaitman
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

3.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Herpesvirus antigens on cell membranes detected by centrifugation of membrane-antibody complexes.

Authors:  B Roizman; P G Spear
Journal:  Science       Date:  1971-01-22       Impact factor: 47.728

5.  Herpesvirus envelopment.

Authors:  R W Darlington; L H Moss
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

6.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

7.  Polysomes and protein synthesis in cells infected with a DNA virus.

Authors:  R J Sydiskis; B Roizman
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

8.  Analysis of C14-labeled proteins by disc electrophoresis.

Authors:  G Fairbanks; C Levinthal; R H Reeder
Journal:  Biochem Biophys Res Commun       Date:  1965-08-16       Impact factor: 3.575

9.  Purification of plasma membranes of rat liver. Application of zonal centrifugation to isolation of cell membranes.

Authors:  R A Weaver; W Boyle
Journal:  Biochim Biophys Acta       Date:  1969-04

10.  Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2.

Authors:  E D Kieff; S L Bachenheimer; B Roizman
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

View more
  63 in total

1.  UL34, the target of the herpes simplex virus U(S)3 protein kinase, is a membrane protein which in its unphosphorylated state associates with novel phosphoproteins.

Authors:  F C Purves; D Spector; B Roizman
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Influence of genetic and physiological properties of the host cell on the cytopathic expression of herpes simplex virus.

Authors:  A M Palenzona; P Sinibaldi; F Costanzo; E Cassai
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.

Authors:  B Norrild; S L Shore; A J Nahmias
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

Review 4.  The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses.

Authors:  B Roizmann; R C Desrosiers; B Fleckenstein; C Lopez; A C Minson; M J Studdert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

6.  Origin of unenveloped capsids in the cytoplasm of cells infected with herpes simplex virus 1.

Authors:  G Campadelli-Fiume; F Farabegoli; S Di Gaeta; B Roizman
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins.

Authors:  R Manservigi; P G Spear; A Buchan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

8.  Polyacrylamide gel electrophoretic analysis of herpes simplex virus type 1 immunoprecipitates obtained by quantitative immunoelectrophoresis in antibody-containing agarose gel.

Authors:  B Norrild; B F Vestergaard
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

9.  Herpes simplex virus envelopment and maturation studied by fracture label.

Authors:  M R Torrisi; C Di Lazzaro; A Pavan; L Pereira; G Campadelli-Fiume
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Differential rates of processing and transport of herpes simplex virus type 1 glycoproteins gB and gC.

Authors:  M Sommer; R J Courtney
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.